Company Overview and News


Add ATRS
to your dashboard

Headline News

Biotech Daily Digest For January 16th

2018-01-16 seekingalpha
Biotech is rising in 2018 but still lags other sectors that will see more direct impacts from the recently passed tax legislation. (685-1)

3 Biotechs For The January Effect

2018-01-03 seekingalpha
In my view, three biotech microcaps may yield among the best risk/reward scenarios for investors today. (182-3)

ATRS INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017

2017-12-22 accesswire
NEW YORK, NY / ACCESSWIRE / December 22, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc. ("Antares") (NASDAQ: ATRS) securities between December 21, 2016 and October 12, 2017. (34-0)

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline - December 22, 2017

2017-12-22 accesswire
NEW YORK, NY / ACCESSWIRE / December 22, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) securities and certain of its officers, on behalf of a class who purchased Antares shares between December 21, 2016, and October 12, 2017, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www. (34-0)

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

2017-12-21 accesswire
NEW YORK, NY / ACCESSWIRE / December 21, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (34-0)

ATRS UPCOMING DEADLINE: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017

2017-12-20 accesswire
NEW YORK, NY / ACCESSWIRE / December 20, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc. ("Antares") (NASDAQ: ATRS) securities between December 21, 2016 and October 12, 2017. (34-0)

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

2017-12-19 accesswire
NEW YORK, NY / ACCESSWIRE / December 19, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (34-0)

Bragar Eagel & Squire, P.C. Reminds Investors That a Class Action Lawsuit Has Been Filed Against Antares Pharma, Inc. (ATRS) and Encourages Investors to Contact the Firm Before December 22nd

2017-12-18 accesswire
NEW YORK, NY / ACCESSWIRE / December 18, 2017 / Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of New Jersey on behalf of all persons or entities who purchased or otherwise acquired Antares Pharma, Inc. (NASDAQ: ATRS) securities between December 21, 2016 and October 12, 2017 (the "Class Period"). Investors have until December 22, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. (34-0)

DEADLINE APPROACHING: The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS)

2017-12-18 accesswire
NEW YORK, NY / ACCESSWIRE / December 18, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Antares Pharma, Inc. (NASDAQ: ATRS) who purchased shares between December 21, 2016 and October 12, 2017. The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws. (34-0)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline - December 22, 2017

2017-12-18 accesswire
NEW YORK, NY / ACCESSWIRE / December 18, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) securities and certain of its officers, on behalf of a class who purchased Antares shares between December 21, 2016, and October 12, 2017, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www. (34-0)

ATRS EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of Commencement of a Class Action Involving Antares Pharma, Inc. and a Lead Plaintiff Deadline of December 22, 2017

2017-12-14 accesswire
NEW YORK, NY / ACCESSWIRE / December 14, 2017 / The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased Antares Pharma, Inc. ("Antares") (NASDAQ: ATRS) securities between December 21, 2016 and October 12, 2017. (34-0)

EQUITY ALERT: Levi & Korsinsky, LLP Reminds Antares Pharma, Inc. Shareholders of Commencement of a Class Action and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

2017-12-13 accesswire
NEW YORK, NY / ACCESSWIRE / December 13, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (34-0)

SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Antares Pharma, Inc. (ATRS) and Lead Plaintiff Deadline: December 22, 2017

2017-12-13 accesswire
NEW YORK, NY / ACCESSWIRE / December 13, 2017 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Antares Pharma, Inc. ("Antares" or the "Company") (NASDAQ: ATRS) securities and certain of its officers, on behalf of a class who purchased Antares shares between December 21, 2016, and October 12, 2017, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: www. (34-0)

The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Antares Pharma, Inc. Shareholders and a Lead Plaintiff Deadline of December 22, 2017 (ATRS)

2017-12-12 accesswire
NEW YORK, NY / ACCESSWIRE / December 12, 2017 / The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Antares Pharma, Inc. (NASDAQ: ATRS) who purchased shares between December 21, 2016 and October 12, 2017. The action, which was filed in the United States District Court for the District of New Jersey, alleges that the Company violated federal securities laws. (34-0)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Antares Pharma, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 22, 2017 - ATRS

2017-12-08 accesswire
NEW YORK, NY / ACCESSWIRE / December 8, 2017 / The following statement is being issued by Levi & Korsinsky, LLP: (34-0)

Stock Research Report

Antares Pharma, Inc. is an emerging, specialty pharmaceutical company that focuses on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. Its strategy is to identify new or existing approved drug formulations and apply its drug delivery technology to enhance the drug compounds and delivery methods. The company develop, manufacture and commercialize, for itself or with partners, novel therapeutic products using its advanced drug delivery systems that are designed to help improve safety and efficacy, reduce side effects, and enhance patient comfort and adherence. Its subcutaneous injection technology platforms include the VIBEX® pressure-assisted auto injector system suitable for branded and generic injectable drugs in unit dose containers, reusable needle-free spring-action injector devices, and disposable multi-dose pen injectors for use with standard cartridges. Antares Pharma has a portfolio of proprietary and partnered pro...

Click for full article
CUSIP: 036642106